Business Description
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 9.47 | |||||
Equity-to-Asset | 0.78 | |||||
Debt-to-Equity | 0.08 | |||||
Debt-to-EBITDA | 0.73 | |||||
Interest Coverage | 6.44 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 11.84 | |||||
Beneish M-Score | 91.14 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 22.2 | |||||
3-Year EPS without NRI Growth Rate | 29.4 | |||||
3-Year FCF Growth Rate | 23.8 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 47.4 | |||||
9-Day RSI | 47.43 | |||||
14-Day RSI | 49.84 | |||||
6-1 Month Momentum % | 17.21 | |||||
12-1 Month Momentum % | 61.9 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.88 | |||||
Quick Ratio | 3.88 | |||||
Cash Ratio | 2.76 | |||||
Days Sales Outstanding | 367.22 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -45.7 | |||||
Shareholder Yield % | -1.43 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | 44.96 | |||||
Net Margin % | 36.51 | |||||
FCF Margin % | -31.57 | |||||
ROE % | 11.91 | |||||
ROA % | 9.03 | |||||
ROIC % | 32.5 | |||||
3-Year ROIIC % | -287.23 | |||||
ROC (Joel Greenblatt) % | 295.4 | |||||
ROCE % | 12.78 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 57.75 | |||||
Forward PE Ratio | 17.2 | |||||
PE Ratio without NRI | 38.97 | |||||
PS Ratio | 20.69 | |||||
PB Ratio | 5.63 | |||||
Price-to-Tangible-Book | 5.91 | |||||
EV-to-EBIT | 46.14 | |||||
EV-to-EBITDA | 42.39 | |||||
EV-to-Revenue | 18.12 | |||||
EV-to-FCF | -57.4 | |||||
Price-to-Graham-Number | 3.27 | |||||
Price-to-Net-Current-Asset-Value | 7.09 | |||||
Price-to-Net-Cash | 11.61 | |||||
Earnings Yield (Greenblatt) % | 2.17 | |||||
FCF Yield % | -1.52 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
AprilBio Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 20,712 | ||
EPS (TTM) (â‚©) | 342 | ||
Beta | 0 | ||
Volatility % | 69.12 | ||
14-Day RSI | 49.84 | ||
14-Day ATR (â‚©) | 1402.840644 | ||
20-Day SMA (â‚©) | 21344.5 | ||
12-1 Month Momentum % | 61.9 | ||
52-Week Range (â‚©) | 10100 - 25550 | ||
Shares Outstanding (Mil) | 21.75 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9999 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
AprilBio Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
AprilBio Co Ltd Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
AprilBio Co Ltd Frequently Asked Questions
What is AprilBio Co Ltd(XKRX:397030)'s stock price today?
When is next earnings date of AprilBio Co Ltd(XKRX:397030)?
Does AprilBio Co Ltd(XKRX:397030) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |